153 reports of this reaction
3.6% of all ALUMINUM HYDROXIDE reports
#4 most reported adverse reaction
SCHIZOAFFECTIVE DISORDER is the #4 most commonly reported adverse reaction for ALUMINUM HYDROXIDE, manufactured by Rugby Laboratories. There are 153 FDA adverse event reports linking ALUMINUM HYDROXIDE to SCHIZOAFFECTIVE DISORDER. This represents approximately 3.6% of all 4,296 adverse event reports for this drug.
Patients taking ALUMINUM HYDROXIDE who experience schizoaffective disorder should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
SCHIZOAFFECTIVE DISORDER is moderately reported among ALUMINUM HYDROXIDE users, representing a notable but not dominant share of adverse events.
In addition to schizoaffective disorder, the following adverse reactions have been reported for ALUMINUM HYDROXIDE:
SCHIZOAFFECTIVE DISORDER has been reported as an adverse event in 153 FDA reports for ALUMINUM HYDROXIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
SCHIZOAFFECTIVE DISORDER accounts for approximately 3.6% of all adverse event reports for ALUMINUM HYDROXIDE, making it a notable side effect.
If you experience schizoaffective disorder while taking ALUMINUM HYDROXIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.